Siemens Healthineers AG(SEMHF)
$48.57-0.68 (-3.66%)
SEMHF
Siemens Healthineers AG financials statements
$48.57
At close:-0.68 (-3.66%)
Siemens Healthineers AG (SEMHF) Ratios
194 Followers
Siemens Healthineers AG Ratios
SEMHF's free cash flow for Q4 2026 was €703.00M. For the 2026 fiscal year, SEMHF's free cash flow was decreased by €-288.00M and operating cash flow was €774.00M. See a summary of the company’s cash flow.
| Ratios | Sep 26 | Sep 25 | Sep 24 | Sep 23 | Sep 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.18 | 1.11 | 1.25 | 1.05 | 1.11 |
| Quick Ratio | 0.84 | 0.79 | 0.89 | 0.73 | 0.78 |
| Cash Ratio | 0.19 | 0.17 | 0.23 | 0.12 | 0.12 |
| Solvency Ratio | 0.13 | 0.13 | 0.11 | 0.11 | 0.12 |
| Operating Cash Flow Ratio | 0.25 | 0.24 | 0.21 | 0.13 | 0.19 |
| Short-Term Operating Cash Flow Coverage | 1.02 | 0.83 | 0.90 | 0.41 | 0.79 |
| Net Current Asset Value | € -11.14B | € -12.18B | € -13.36B | € -14.41B | € -15.82B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.32 | 0.34 | 0.35 | 0.36 | 0.34 |
| Debt-to-Equity Ratio | 0.74 | 0.83 | 0.89 | 0.92 | 0.84 |
| Debt-to-Capital Ratio | 0.43 | 0.46 | 0.47 | 0.48 | 0.46 |
| Long-Term Debt-to-Capital Ratio | 0.37 | 0.38 | 0.42 | 0.40 | 0.40 |
| Financial Leverage Ratio | 2.35 | 2.46 | 2.53 | 2.58 | 2.47 |
| Debt Service Coverage Ratio | 1.06 | 0.94 | 1.13 | 0.72 | 1.19 |
| Interest Coverage Ratio | 7.83 | 8.08 | 6.93 | 8.24 | 25.97 |
| Debt to Market Cap | 0.35 | 0.28 | 0.26 | 0.30 | 0.33 |
| Interest Debt Per Share | 13.63 | 13.83 | 14.95 | 15.14 | 14.94 |
| Net Debt to EBITDA | 2.72 | 2.81 | 3.20 | 3.97 | 3.57 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.57% | 38.63% | 37.87% | 35.56% | 37.47% |
| EBIT Margin | 13.96% | 14.07% | 13.42% | 10.24% | 13.43% |
| EBITDA Margin | 18.98% | 19.61% | 18.89% | 17.43% | 19.61% |
| Operating Profit Margin | 13.52% | 14.70% | 14.76% | 11.25% | 14.11% |
| Pretax Profit Margin | 12.23% | 12.21% | 11.28% | 8.89% | 12.89% |
| Net Profit Margin | 9.37% | 9.17% | 8.68% | 6.96% | 9.39% |
| Continuous Operations Profit Margin | 9.50% | 9.27% | 8.76% | 7.03% | 9.46% |
| Net Income Per EBT | 76.61% | 75.15% | 76.97% | 78.27% | 72.79% |
| EBT Per EBIT | 90.48% | 83.06% | 76.45% | 79.02% | 91.38% |
| Return on Assets (ROA) | 4.74% | 4.83% | 4.22% | 3.23% | 4.15% |
| Return on Equity (ROE) | 11.15% | 11.88% | 10.67% | 8.35% | 10.27% |
| Return on Capital Employed (ROCE) | 9.54% | 10.83% | 9.57% | 7.34% | 8.27% |
| Return on Invested Capital (ROIC) | 6.76% | 7.36% | 6.88% | 5.13% | 5.64% |
| Return on Tangible Assets | 9.73% | 10.34% | 9.10% | 7.24% | 9.58% |
| Earnings Yield | 5.25% | 4.16% | 3.23% | 2.81% | 4.10% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.26 | 3.22 | 3.10 | 2.90 | 3.07 |
| Payables Turnover | 5.68 | 6.25 | 6.54 | 6.34 | 5.86 |
| Inventory Turnover | 3.21 | 3.47 | 3.32 | 3.25 | 3.39 |
| Fixed Asset Turnover | 4.62 | 4.96 | 5.00 | 5.15 | 5.08 |
| Asset Turnover | 0.51 | 0.53 | 0.49 | 0.46 | 0.44 |
| Working Capital Turnover Ratio | 12.16 | 10.81 | 12.54 | 21.14 | 21.46 |
| Cash Conversion Cycle | 161.47 | 160.24 | 171.53 | 180.63 | 164.28 |
| Days of Sales Outstanding | 112.03 | 113.44 | 117.60 | 126.00 | 118.74 |
| Days of Inventory Outstanding | 113.70 | 105.21 | 109.78 | 112.18 | 107.78 |
| Days of Payables Outstanding | 64.27 | 58.42 | 55.85 | 57.55 | 62.24 |
| Operating Cycle | 225.74 | 218.66 | 227.37 | 238.18 | 226.52 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 2.96 | 2.75 | 2.21 | 1.62 | 2.01 |
| Free Cash Flow Per Share | 2.20 | 2.02 | 1.59 | 0.87 | 1.25 |
| Dividend Paid and CapEx Coverage Ratio | 1.68 | 1.64 | 1.40 | 0.95 | 1.25 |
| Capital Expenditure Coverage Ratio | 3.90 | 3.77 | 3.55 | 2.16 | 2.65 |
| Operating Cash Flow Coverage Ratio | 0.22 | 0.20 | 0.15 | 0.11 | 0.14 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.13 | 0.11 | 0.08 | 0.10 |
| Free Cash Flow Yield | 5.79% | 4.40% | 2.95% | 1.81% | 2.82% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 19.08 | 24.09 | 30.95 | 35.61 | 24.40 |
| Price-to-Sales (P/S) Ratio | 1.79 | 2.20 | 2.69 | 2.48 | 2.29 |
| Price-to-Book (P/B) Ratio | 2.13 | 2.86 | 3.30 | 2.97 | 2.51 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.26 | 22.75 | 33.90 | 55.34 | 35.41 |
| Price-to-Operating Cash Flow Ratio | 12.84 | 16.72 | 24.35 | 29.70 | 22.04 |
| Price-to-Earnings Growth (PEG) Ratio | 4.56 | 2.47 | 1.07 | -1.38 | 1.53 |
| Enterprise Value Multiple | 12.13 | 14.05 | 17.43 | 18.20 | 15.25 |
| Enterprise Value | 54.40B | 64.42B | 73.64B | 68.75B | 64.93B |
| EV to EBITDA | 12.13 | 14.05 | 17.43 | 18.20 | 15.25 |
| EV to Sales | 2.30 | 2.76 | 3.29 | 3.17 | 2.99 |
| EV to Free Cash Flow | 22.25 | 28.44 | 41.53 | 70.80 | 46.25 |
| EV to Operating Cash Flow | 16.55 | 20.90 | 29.83 | 38.00 | 28.78 |
| Tangible Book Value Per Share | -3.63 | -4.95 | -5.80 | -6.89 | -7.05 |
| Shareholders’ Equity Per Share | 17.86 | 16.11 | 16.31 | 16.15 | 17.67 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.22 | 0.24 | 0.22 | 0.21 | 0.27 |
| Revenue Per Share | 21.26 | 20.87 | 20.04 | 19.37 | 19.34 |
| Net Income Per Share | 1.99 | 1.91 | 1.74 | 1.35 | 1.82 |
| Tax Burden | 0.77 | 0.75 | 0.77 | 0.78 | 0.73 |
| Interest Burden | 0.88 | 0.87 | 0.84 | 0.87 | 0.96 |
| Research & Development to Revenue | 0.08 | 0.08 | 0.09 | 0.09 | 0.08 |
| SG&A to Revenue | 0.17 | 0.16 | 0.15 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.47 | 1.44 | 1.27 | 1.20 | 1.11 |
Currency in EUR
